Literature DB >> 16791582

Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam.

Sándor Drabant, Mária Tóth, Andrea Bereczki, Judit Bajnógel, Judit Tömlö, Imre Klebovich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16791582     DOI： 10.1007/s00228-006-0160-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  [Effect of tofisopam on CYP3A4 enzyme activity on human recombinant 3A4 supersome].

Authors:  Mária Tóth; Judit Bajnógel; András Egyed; Sándor Drabant; Judit Tömlo; Imre Klebovich
Journal:  Acta Pharm Hung       Date:  2005

Review 2.  Drug interactions with tacrolimus.

Authors:  Teun van Gelder
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
  2 in total
  1 in total

1.  Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.

Authors:  Mária Tóth; Sándor Drabant; Bálint Varga; Gyula Végso; Anna Cseh; Imre Szentpéteri; Imre Klebovich
Journal:  Eur J Clin Pharmacol       Date:  2007-11-08       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.